Ryan Savitz, EVP, CFO & Cbo: Dianthus Therapeutics DNTH Sell · Filed 04/01

Trade details

Type: Insider sale
Amount: $5,017,220
Shares · price: 59,800 sh · $83.90 a share
Held after: 26,701 sh
Stock: Dianthus Therapeutics DNTH
Person: Ryan SavitzEVP, CFO & Cbo
Trade date: 26/03/31
Filed: 26/04/01
Days to filing: 1 days

Sold 69.1% of holdings

Share of holding sold: 69.1%

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Ryan Savitz's recent trades

Ryan SavitzEVP, CFO & Cbo
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$3.1M
31,249 sh
$3.1M
Filed 07/09
Traded 07/09
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$738.8K
8,224 sh
$738.8K
Filed 04/10
Traded 04/09
Ryan SavitzEVP, CFO & Cbo
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$719.4K
8,224 sh
$719.4K
Filed 04/09
Traded 04/09
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$1.7M
21,825 sh
$1.7M
Filed 04/01
Traded 03/31
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$1.6M
19,469 sh
$1.6M
Filed 04/01
Traded 03/31

Ryan Savitz, CFO — sold $5M of Dianthus Therapeutics DNTH · 69.1% of holdings · 10b5-1 plan | Whalegun